Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16510263rdf:typepubmed:Citationlld:pubmed
pubmed-article:16510263lifeskim:mentionsumls-concept:C0024660lld:lifeskim
pubmed-article:16510263lifeskim:mentionsumls-concept:C1383501lld:lifeskim
pubmed-article:16510263lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:16510263lifeskim:mentionsumls-concept:C0039941lld:lifeskim
pubmed-article:16510263lifeskim:mentionsumls-concept:C0206108lld:lifeskim
pubmed-article:16510263lifeskim:mentionsumls-concept:C1880371lld:lifeskim
pubmed-article:16510263pubmed:issue6lld:pubmed
pubmed-article:16510263pubmed:dateCreated2006-6-26lld:pubmed
pubmed-article:16510263pubmed:abstractTextThioredoxin reductase (TrxR) reduces thioredoxin (Trx), thereby contributing to cellular redox balance, facilitating the synthesis of deoxy-ribose sugars for DNA synthesis, and regulating redox-sensitive gene expression. Auranofin is a gold compound that potently inhibits TrxR. This inhibition is one suspected mechanism of auranofin's therapeutic benefit in the treatment of rheumatoid arthritis. The use of other gold compounds to treat cancer or inflammatory disease may rely on their ability to inhibit TrxR. In the current study, we tested the hypothesis that a variety of gold compounds may inhibit TrxR.lld:pubmed
pubmed-article:16510263pubmed:languageenglld:pubmed
pubmed-article:16510263pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:citationSubsetIMlld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16510263pubmed:statusMEDLINElld:pubmed
pubmed-article:16510263pubmed:monthSeplld:pubmed
pubmed-article:16510263pubmed:issn0887-2333lld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:WatahaJohn...lld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:LockwoodPetra...lld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:LewisJill BJBlld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:SanoHidehikoHlld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:BouillaguetSe...lld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:MesserRegina...lld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:ShawMelissaMlld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:OmataYoYlld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:HobbsDavidDlld:pubmed
pubmed-article:16510263pubmed:authorpubmed-author:FolanMattMlld:pubmed
pubmed-article:16510263pubmed:issnTypePrintlld:pubmed
pubmed-article:16510263pubmed:volume20lld:pubmed
pubmed-article:16510263pubmed:ownerNLMlld:pubmed
pubmed-article:16510263pubmed:authorsCompleteYlld:pubmed
pubmed-article:16510263pubmed:pagination882-90lld:pubmed
pubmed-article:16510263pubmed:dateRevised2009-4-10lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:meshHeadingpubmed-meshheading:16510263...lld:pubmed
pubmed-article:16510263pubmed:year2006lld:pubmed
pubmed-article:16510263pubmed:articleTitleSublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).lld:pubmed
pubmed-article:16510263pubmed:affiliationHokkaido University, Sapporo, Japan.lld:pubmed
pubmed-article:16510263pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16510263pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16510263lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16510263lld:pubmed